Detalhe da pesquisa
1.
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
Blood
; 143(13): 1231-1241, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38145560
2.
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects.
J Clin Oncol
; 39(13): 1415-1425, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507803